Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Adverse Effect
5%
Adverse Event
25%
Alzheimer's Disease
11%
Antidepressant
50%
Antipsychotic Drug
33%
Arm
16%
Atypical Antipsychotic
9%
Awareness
11%
Base
22%
Brain Disease
33%
Chronic Fatigue Syndrome
100%
Clinical Trials Unit
5%
Cognitive Behavioral Therapy
100%
Cohen Mansfield Agitation Inventory
11%
Cornell Scale for Depression in Dementia
16%
Cost-Effectiveness Analysis
66%
Diabetes
33%
Diabetes Mellitus
33%
Drug Therapy
10%
Graded Exercise Therapy
38%
Group Therapy
5%
Group Therapy
5%
Health Care
13%
Health Technology
5%
Impaired Fasting Glucose
33%
Intervention Trial
16%
Linear Regression Analysis
5%
Medical Care
100%
Mirtazapine
66%
Odds Ratio
9%
Placebo
66%
Prevalence
19%
Psychogeriatrics
5%
Quality of Life
22%
Randomized Controlled Trial
66%
Sertraline
66%
Social Isolation
11%
Specialist Care
11%
Technology Assessment
5%
Treatment of Depression
5%
Nursing and Health Professions
4 Iodo 2,5 Dimethoxyamphetamine
33%
Adolescent
33%
Attention Deficit Disorder
33%
Atypical Antipsychotic
33%
Blood Pressure
11%
Central Stimulant Agent
5%
Chronic Fatigue Syndrome
33%
Clinical Global Impression Scale
5%
Clozapine
16%
Cognitive Behavioral Therapy
33%
Cohen Mansfield Agitation Inventory
44%
Combination Therapy
5%
Compliance
27%
Confidence Interval
11%
Cost Effectiveness Analysis
66%
Diabetes Mellitus
16%
Diseases
11%
Drug Dose Titration
5%
Drug Megadose
5%
Effect Size
5%
Experimental Design
6%
External Validity
33%
Health Care
44%
Intellectual Impairment
33%
Intention to Treat Analysis
5%
Internal Validity
33%
Loss of Appetite
5%
medical rehabilitation
33%
Methylphenidate
33%
Mirtazapine
33%
Odds Ratio
16%
Olanzapine
16%
Optimal Drug Dose
33%
Patient Referral
5%
Pilot Study
33%
Placebo
44%
Polypharmacy
16%
Pulse Pressure
11%
Quality of Life
29%
Randomization
33%
Rating Scale
5%
Sertraline
33%
Social Isolation
11%
Specialist Care
11%
Neuroscience
Adverse Effect
11%
Alzheimer's Disease
11%
Analeptic
5%
Antidepressant
19%
Antipsychotic
66%
Attention Deficit Hyperactivity Disorder
33%
Atypical Antipsychotic
55%
Chronic Fatigue Syndrome
66%
Clozapine
16%
Cognitive Behavioral Therapy
66%
Diabetes Mellitus
50%
Drug Therapy
16%
Group Therapy
18%
Hyperkinetic Disorder
11%
Methylphenidate
33%
Mirtazapine
66%
Olanzapine
16%
Placebo
77%
Psychogeriatrics
5%
Randomized Controlled Trial
33%
Sertraline
66%
Treatment of Depression
5%
